Opportunities, Challenges, and What Works in Low-Resource Settings
Postpartum family planning (PPFP) represents one of the most significant unmet needs in global reproductive health. An estimated 220 million women in low- and middle-income countries have an unmet need for contraception — and the period immediately following childbirth is a critical window to close that gap. The Postpartum Intrauterine Contraceptive Device (PPIUCD) has emerged as one of the most effective, cost-efficient, and scalable interventions available to governments, NGOs, and health systems committed to FP2030 goals.
This article is written for program managers, procurement officers, public health officials, UNFPA/USAID partners, and clinical trainers involved in national family planning strategies. It outlines the evidence base for PPIUCD, common implementation barriers, and strategies that have produced measurable scale in diverse settings.
The Case for Postpartum IUD in Public Health Programs
The postpartum period creates a unique opportunity. Women are in contact with the health system, are highly motivated to space or limit births, and have immediate access to skilled providers who can perform insertion safely. An IUD inserted within 10 minutes of placental delivery or within 48 hours postpartum — before uterine involution — is as effective as an interval insertion, with an expulsion rate of 10–12%, which is manageable at scale.
The RMNCHA+ strategy in India — integrated under the National Health Mission — explicitly prioritises PPIUCD as a core postpartum family planning method. Similar frameworks exist under USAID’s Maternal and Child Survival Program (MCSP) and UNFPA’s Family Planning 2030 commitment.
A WHO systematic review of PPIUCD programs in South Asia found that where provider training and patient counselling were standardised, PPIUCD acceptance rates reached 30–60% among eligible postpartum women — compared to under 10% without dedicated programming.
What Makes a PPIUCD Program Work
Evidence from successful programs in India, Ethiopia, Kenya, and Bangladesh points to five non-negotiable design elements:
1. Antenatal Counselling as the Foundation
Acceptance decisions cannot realistically be made in the immediate postpartum period. Women who were counselled on PPIUCD during their second or third trimester antenatal visit — with time to discuss with family, if relevant to their cultural context — show significantly higher acceptance rates at delivery. Programs that attempt counselling only at the time of delivery consistently underperform.
2. Trained Providers at Every Delivery Point
PPIUCD insertion is a technical skill that requires specific training, particularly for managing the fundal placement technique post-delivery. In programs that have successfully scaled, every skilled birth attendant — not just gynaecologists — is trained and credentialed for insertion. Task-sharing is essential at volume.
3. Supportive Supervision, Not Just Training
Training alone does not maintain competency. Programs that incorporate quarterly supervision visits, where a senior clinician observes and provides feedback on insertions, show sustained quality over time. Without supervision, skill decay and insertion hesitancy are common within six months of training.
4. Supply Chain Reliability
Stockouts are among the most commonly reported barriers in government PPIUCD programs. A woman who accepts PPIUCD during her antenatal visit and arrives at the delivery facility to find no devices available will not return for interval insertion in most contexts. Robust procurement — from WHO-prequalified manufacturers with reliable delivery timelines — is a program design requirement, not a procurement afterthought.
5. Community Demand Generation
Even in high-coverage antenatal programs, acceptance rates plateau without community-level demand. ASHA workers, ANMs, and community health volunteers play a critical role in normalising PPIUCD at the household level, particularly in communities where IUD myths remain prevalent. Their training and motivation incentives must be built into program budgets.
Common Implementation Barriers and How to Address Them
- Provider hesitancy:Address through competency-based training with simulation models (phantom trainers) before live insertion. Confidence is built by repetition in low-stakes settings.
- Expulsion concerns: Standardise fundal placement technique. Track expulsion rates by provider and use data for targeted retraining rather than program-wide alarm.
- Family opposition:Involve the woman’s decision-making network (partner, mother-in-law in relevant contexts) in counselling where appropriate and culturally acceptable. Do not impose, but do not assume opposition.
- Follow-up gaps:Default follow-up should be at 4–6 weeks postpartum, ideally aligned with the postnatal care visit. Bundle the IUD check with mother and infant health assessments.
- Lack of data: Implement a simple register or digital tool to track insertion rates, expulsions, removals, and conversions by facility. Programs that measure outperform those that do not.
The FP2030 Alignment Case
PPIUCD programs are inherently aligned with FP2030 commitments because they deliver long-acting, reversible contraception to high-need populations at the moment they are most accessible to the health system. Cost-effectiveness analyses consistently show PPIUCD as one of the lowest cost-per-DALY-averted interventions in reproductive health.
For bilateral and multilateral donors, PPIUCD programs offer a credible, evidence-backed investment. The device cost is low; the training cost is moderate; the infrastructure requirement is minimal (any facility conducting deliveries); and the impact — measured in birth spacing, maternal health, and newborn outcomes — is substantial.
Procurement Considerations for Government and NGO Buyers
At the program level, device selection should be based on WHO prequalification status, demonstrated quality consistency across shipments, shelf life, and manufacturer capacity to meet volume requirements reliably. Programs operating at scale (100,000+ units annually) require suppliers with certified clean-room manufacturing, documented sterility validation, and regulatory clearance in the procuring country.
SMB Corporation’s copper IUDs have been supplied to government health programs across more than 60 countries. The company operates WHO-compliant manufacturing facilities in India and has a multi-decade track record in UNFPA and USAID supply chains.
Conclusion
PPIUCD is not a niche intervention. It is a high-impact, scalable, cost-effective tool that belongs at the centre of government family planning programs. The evidence is clear; the implementation lessons are well-documented. What scales PPIUCD is the same as what scales any effective health program: committed leadership, trained providers, reliable supply, and data-driven management.
SMB Corporation partners with governments, NGOs, and procurement agencies on PPIUCD supply and provider training resources. Learn more at www.smbcorpn.com
